CA Elmets, CL Leonardi, DMR Davis… - Journal of the American …, 2019 - Elsevier
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities - ScienceDirect Skip to main contentSkip to article …
SA Hasni, S Gupta, M Davis, E Poncio… - Nature …, 2021 - nature.com
Increased risk of premature cardiovascular disease (CVD) is well recognized in systemic lupus erythematosus (SLE). Aberrant type I-Interferon (IFN)-neutrophil interactions contribute …
Psoriasis is a chronic inflammatory skin disease that affects 2% to 3% of the US population. The immune response in psoriasis includes enhanced activation of T cells and myeloid …
EJ Armstrong, CT Harskamp… - Journal of the American …, 2013 - Am Heart Assoc
Background Psoriasis is a chronic inflammatory disease that may be associated with increased risk of cardiovascular events, including cardiovascular mortality, myocardial …
W Masson, M Lobo, G Molinero - Advances in therapy, 2020 - Springer
Psoriasis is a systemic inflammatory disorder that involves complex pathogenic interactions between the innate and adaptive immune systems. Individuals with psoriasis have an …
J Takeshita, S Grewal, SM Langan, NN Mehta… - Journal of the American …, 2017 - Elsevier
As summarized in the first article in this continuing medical education series, the currently available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic …
KR Feingold, C Grunfeld - Endotext [internet], 2022 - ncbi.nlm.nih.gov
Chronic inflammatory diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and psoriasis and infections, such as periodontal disease and HIV …
C Ryan, B Kirby - Dermatologic clinics, 2015 - derm.theclinics.com
Once considered to be solely a cutaneous disease, there is now robust evidence that psoriasis is associated with systemic inflammation and a significantly increased risk of …
Psoriasis is a T helper type 17 autoimmune disease associated with an increased risk cardiovascular events and mortality. Ustekinumab, an antibody to p40, blocks cytokines IL …